Figures & data
Figure 1 The BETACONNECT™ device.
Notes: (A) The electronic autoinjector BETACONNECT™ has an ergonomic, user-friendly design with optical and acoustic control of the injection process. (B) The syringe for interferon beta-1b release is placed into the autoinjector. The needle is hidden during the entire injection process. Besides other features, the device contains a contact sensor for avoidance of unintentional release.
Table 1 Demographic characteristics of participants
Table 2 BETACONNECT™ – specific characteristics of participants
Figure 2 Rating of the support provided by the BETACONNECT™ device in interferon beta-1b therapy.
Notes: Patient evaluation of the support provided by the autoinjector (A) in the total survey population and substratified for (B) men, women, and patients without sex specification as well as for (C) duration of interferon beta-1b therapy. Rating scale comprised “very helpful”, “helpful”, “less helpful”, “not helpful”, and “not specified”. Values are represented as mean percentages.
Abbreviation: NS, not specified.
Abbreviation: NS, not specified.
Figure 3 Rating of the BETACONNECT™ function and features in patient support (n=1,365).
Notes: Evaluation of features by provision of support (A) in therapy and (B) substratified for the categories “very important/important” and “less important/not important”. (C) Rating of features as “very important/important” substratified for duration of therapy. (B, C) Multiple selections possible.
Figure 4 Evaluation of the BETACONNECT™.
Notes: (A) Rating of the autoinjection device with ranking from “very good” to “unsatisfactory”. (B) Proportion of patients, who would recommend BETACONNECT™, categorized by “very likely/likely” and “less likely/very unlikely” and substratified for the total population, men, women, and the proportion without sex specification. Values are represented as mean percentages.
